2017
DOI: 10.1186/s12891-017-1809-5
|View full text |Cite
|
Sign up to set email alerts
|

Can hybrid hyaluronic acid represent a valid approach to treat rizoarthrosis? A retrospective comparative study

Abstract: BackgroundOsteoarthritis (OA) of the trapeziometacarpal joint (TMJ) is a disabling condition with a significant impact on quality of life. The optimal management of hand OA requires a combination of non-pharmacological and pharmacological treatments that include intra-articular (i.a.) therapy. EULAR experts recommend corticosteroid injections in TMJ OA and underline the usefulness of hyaluronic acid (HA). The aim of this study was the assessment of the efficacy and tolerability of i.a. injections of a hybrid f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
20
0
1

Year Published

2019
2019
2020
2020

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 15 publications
(22 citation statements)
references
References 31 publications
1
20
0
1
Order By: Relevance
“…Additionally, pain reduction with HA was more gradual and long term, while CS was more acute [14]. In a systematic review of studies evaluating outcomes 6 months after injection, global hand pain, functionality, morning stiffness, and measures of perceived health were significantly improved in HA therapy [15]. One study that investigated combination HA and ketorolac intra-articular injections in the CMC joint revealed that the therapy improved pain at 1 month compared to HA alone [16].…”
Section: Intra-articular Therapiesmentioning
confidence: 99%
“…Additionally, pain reduction with HA was more gradual and long term, while CS was more acute [14]. In a systematic review of studies evaluating outcomes 6 months after injection, global hand pain, functionality, morning stiffness, and measures of perceived health were significantly improved in HA therapy [15]. One study that investigated combination HA and ketorolac intra-articular injections in the CMC joint revealed that the therapy improved pain at 1 month compared to HA alone [16].…”
Section: Intra-articular Therapiesmentioning
confidence: 99%
“…Nevertheless, no significant differences were found between the two groups for all outcomes evaluated. Previous studies evaluated the efficacy of viscosupplementation for rhizarthrosis reporting promising results (9)(10)(11)(16)(17)(18)(19)(20). However, the comparison with the other trials present in the literature is often difficult due to the heterogeneity of protocol design, treatments (different type of HA, comparison with others intra-articular injection therapies) and time of follow-up used.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, Velasco et al performed a single arm-study; we think that the presence of a control-group is essential to validate their findings. In a retrospective study, Tenti and collaborators analyzed the clinical data of 100 patients with unilateral or bilateral TMC OA, received 2 infiltrations of a hybrid formulation of HA (Sinovial H-L) or triamcinolone acetonide (Triamcinolone Group) (11). All patients were investigated at the time of the first and second injection and after one, 3-and 6-months using VAS and the Functional Index for Hand OA (FIHOA) as primary outcomes, and the duration of morning stiffness, the Health Assessment Questionnaire (HAQ) and the Medi-cal Outcomes Study 36-Item Short Form (SF-36) as secondary outcomes.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations